Chip Stewart

Broad Institute — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

87h-index67.2kcitations396works2.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(108), Multiple Myeloma Research and Treatments(67), Myeloproliferative Neoplasms: Diagnosis and Treatment(33), Sarcoma Diagnosis and Treatment(29), Genetic factors in colorectal cancer(29)

Publications310 total

Supplementary Figures and Tables from MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology
2025Open Access
Supplemental Figure 5 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer
2025Open Access
Supplemental Figure 2 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer
2025Open Access
Supplemental Figure 6 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer
2025Open Access
Supplementary Data from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer
2025Open Access
Supplemental Figure 1 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer
2025Open Access
Supplemental Figure 4 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer
2025Open Access
Supplemental Figure 3 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer
2025Open Access
Supplementary Data from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer
2025Open Access
Relapsed diffuse large B-cell lymphoma is shaped by molecular subtypes and genomic alterations
Blood·2025Open Access
Circulating tumor DNA analyses of molecular tumor burden are superior to PET-assessed responses in patients with advanced stage classic Hodgkin lymphoma treated on SWOG S1826
Blood·2025Open Access
Systematic molecular profiling to identify determinants of response to ibrutinib
Blood·2025Open Access
Detection of heterogeneous resistance mechanisms to tyrosine kinase inhibitors from cell-free DNA
Cell Genomics·2025Open Access
Tamoxifen induces PI3K activation in uterine cancer
Nature Genetics·2025· 5 citedOpen Access
Abstract PS18-06: Primary results and the transcriptomic analysis of PELOPS, a randomized phase II study of neoadjuvant palbociclib with or without endocrine therapy for breast cancer patients with invasive lobular carcinoma or invasive ductal carcinoma
Clinical Cancer Research·2025· 1 cited
21 | PROGNOSTIC VALUE OF CIRCULATING TUMOR DNA IN PATIENTS WITH ADVANCED STAGE CLASSIC HODGKIN LYMPHOMA TREATED ON SWOG S1826
Hematological Oncology·2025· 4 citedOpen Access
LBA1 | THE BENEFIT OF POLA‐R‐CHP IN DLBclass‐DEFINED MOLECULAR SUBSETS OF NEWLY DIAGNOSED DLBCL IN THE POLARIX TRIAL
Hematological Oncology·2025· 6 citedOpen Access
Genomic landscape of multiple myeloma and its precursor conditions
Nature Genetics·2025· 20 citedOpen Access
Abstract 6437: Mutational patterns in normal tissue hold the key to understanding the cellular origins of cancer
Cancer Research·2025
SVelfie: A method for discovering cancer drivers based on enrichment of likely functional structural variants
2025· 1 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

Gad Getz(40), Michael S. Lawrence(21), Kristian Cibulskis(16), Scott L. Carter(15), Stacey Gabriel(15), Matthew Meyerson(15), Amaro Taylor‐Weiner(12), Julian M. Hess(12), Carrie Sougnez(11), Mara Rosenberg(11), Jaegil Kim(11), Aaron McKenna(10), Rameen Beroukhim(10), Eric S. Lander(10), Todd R. Golub(9), Steven E. Schumacher(9), Andrew Dunford(9), Gordon Saksena(8), Ignaty Leshchiner(8), Petar Stojanov(7)